Amesite Announces Closing of Public Offering
Amesite Inc. (Nasdaq: AMST) has announced the closing of its 'best efforts' underwritten public offering, raising approximately $3.6 million through the sale of 1,201,667 shares of common stock at $3.00 per share. Company officers and directors participated in the offering with subscriptions totaling about $1.26 million.
The offering was jointly managed by Laidlaw & Company (UK) and Craft Capital Management The company plans to utilize the net proceeds for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. The offering was conducted under a previously filed and effective shelf registration statement on Form S-3.
Amesite Inc. (Nasdaq: AMST) ha annunciato la chiusura della sua offerta pubblica sottoscritta 'migliori sforzi', raccogliendo circa 3,6 milioni di dollari attraverso la vendita di 1.201.667 azioni ordinarie a 3,00 dollari per azione. I dirigenti e i direttori dell'azienda hanno partecipato all'offerta con sottoscrizioni totali di circa 1,26 milioni di dollari.
L'offerta è stata gestita congiuntamente da Laidlaw & Company (UK) e Craft Capital Management. L'azienda prevede di utilizzare il ricavato netto per scopi aziendali generali, spese in conto capitale, capitale circolante e spese generali e amministrative. L'offerta è stata condotta sulla base di una registrazione shelf precedentemente depositata e valida, in base al modulo S-3.
Amesite Inc. (Nasdaq: AMST) ha anunciado el cierre de su oferta pública suscrita de 'mejores esfuerzos', recaudando aproximadamente 3.6 millones de dólares a través de la venta de 1,201,667 acciones comunes a 3.00 dólares por acción. Los funcionarios y directores de la empresa participaron en la oferta con suscripciones que totalizaron alrededor de 1.26 millones de dólares.
La oferta fue gestionada conjuntamente por Laidlaw & Company (UK) y Craft Capital Management. La empresa planea utilizar los ingresos netos para fines corporativos generales, gastos de capital, capital de trabajo y gastos generales y administrativos. La oferta se llevó a cabo bajo una declaración de registro shelf previamente presentada y efectiva en el formulario S-3.
Amesite Inc. (Nasdaq: AMST)는 '최선의 노력' 공개 모집을 종료하고 360만 달러를 달성했다고 발표했습니다. 이는 주당 3.00 달러에 1,201,667주를 판매한 결과입니다. 회사 임원과 이사들은 약 126만 달러 규모의 구독에 참여했습니다.
이번 모집은 Laidlaw & Company (UK)와 Craft Capital Management가 공동으로 관리했습니다. 회사는 순이익을 일반 기업 목적, 자본 지출, 운영 자본 및 일반 및 관리 비용에 사용할 계획입니다. 이 모집은 이전에 제출된 유효한 선반 등록 신고서에 따라 이루어졌습니다. (Form S-3)
Amesite Inc. (Nasdaq: AMST) a annoncé la clôture de son offre publique souscrite 'meilleures efforts', levant environ 3,6 millions de dollars par la vente de 1.201.667 actions ordinaires à 3,00 dollars par action. Les dirigeants et administrateurs de l'entreprise ont participé à l'offre avec des souscriptions totalisant environ 1,26 million de dollars.
L'offre a été gérée conjointement par Laidlaw & Company (UK) et Craft Capital Management. L'entreprise prévoit d'utiliser le produit net à des fins corporatives générales, pour des dépenses en capital, pour le fonds de roulement ainsi que pour les frais généraux et administratifs. L'offre a été réalisée en vertu d'une déclaration d'enregistrement shelf préalablement déposée et effective au formulaire S-3.
Amesite Inc. (Nasdaq: AMST) hat den Abschluss ihrer 'Best Efforts'-öffentlichen Platzierung bekannt gegeben, durch die etwa 3,6 Millionen Dollar durch den Verkauf von 1.201.667 Stammaktien zu einem Preis von 3,00 Dollar pro Aktie erzielt wurden. Unternehmensbeauftragte und -vorstände nahmen mit Zeichnungen von insgesamt etwa 1,26 Millionen Dollar an der Platzierung teil.
Die Platzierung wurde gemeinsam von Laidlaw & Company (UK) und Craft Capital Management geleitet. Das Unternehmen plant, die Nettoerlöse für allgemeine Unternehmenszwecke, Investitionsausgaben, Betriebskapital sowie Allgemein- und Verwaltungskosten zu verwenden. Die Platzierung wurde auf der Grundlage einer zuvor eingereichten und wirksamen Shelf-Registrierungserklärung auf dem Formular S-3 durchgeführt.
- Successfully raised $3.6 million through public offering
- Strong insider participation with $1.26 million subscribed by officers and directors
- Secured funding for working capital and corporate operations
- Potential dilution of existing shareholders' equity
- Share offering price of $3.00 indicates capital raised at current market conditions
Insights
This
The dilutive impact is considerable, with 1,201,667 new shares being issued, representing a significant portion of the company's float. However, the insider participation helps mitigate concerns about value destruction. The 'best efforts' structure indicates some challenges in securing traditional firm commitment underwriting, typical for micro-cap offerings.
The stated use of proceeds for general corporate purposes and working capital suggests this is primarily a survival-focused raise rather than a growth-oriented one. Companies at this market cap typically burn through
In the competitive AI solutions market, this capital injection provides Amesite with essential resources to maintain its B2B and B2C AI development initiatives. The timing aligns with increased market demand for AI-driven educational technology solutions, though Amesite faces intense competition from well-funded rivals.
The participation of company insiders in the offering suggests confidence in Amesite's AI technology roadmap and market positioning. However, the relatively modest size of the raise may limit the company's ability to accelerate product development or expand market presence significantly compared to larger competitors in the space.
For context, successful AI-driven edtech companies typically require substantial capital for R&D and market penetration - often
DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC acted as joint book-running managers for the offering.
The Company intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital and general and administrative expenses.
A shelf registration statement on Form S-3 (Registration No. 333-282999) relating to the public offering of the securities described above was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the underwritten public offering was filed with the SEC and are available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering may be obtained from Laidlaw & Company (UK) Ltd., 521 Fifth Ave., 12th Floor, New York, NY 10175, Attention: Syndicate Dept.; email: syndicate@laidlawltd.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s anticipated public offering, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
FAQ
How much did Amesite (AMST) raise in its January 2025 public offering?
What was the participation level of AMST insiders in the January 2025 offering?
How will Amesite (AMST) use the proceeds from its 2025 public offering?